C.T. Fitzpatrick’s Novartis NVS Stock Holding History

C.T. Fitzpatrick’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-335	Closed	-$28K	–	74
2014 Q3	$28K	Sell	335 -312	-48%	-$25.2K	﹤0.01%	71
2014 Q2	$53K	Buy	+647	New	+$50.9K	﹤0.01%	63

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 16.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

C.T. Fitzpatrick's NVS Position: Q4 2014 in Review

C.T. Fitzpatrick sold out of Novartis (NVS) in Q4 2014, closing a stake of 335 shares — an estimated $28K sold.

C.T. Fitzpatrick first reported a position in NVS in Q2 2014 and held it in 2 quarters. The position peaked at $53K in Q2 2014. 919 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

C.T. Fitzpatrick reported no remaining Novartis position as of Q4 2014 after selling out during the quarter.
C.T. Fitzpatrick sold 335 Novartis shares in Q4 2014, an estimated $28K.
C.T. Fitzpatrick first reported a position in Novartis in Q2 2014 and held it in 2 quarters.
C.T. Fitzpatrick's Novartis position peaked at $53K in Q2 2014.
919 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on Vulcan Value Partners's 13F filing for Q4 2014, filed 17 Feb 2015.